"A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant"

If you are interested in learning more about this trial, ResearchMatch can help by contacting the trial team for you. If you’re not a volunteer yet, you’ll first need to join ResearchMatch before we can share your contact information with the research team.